Afferent Phase Production of TNF-α Is Required for the Development of Protective T Cell Immunity to Cryptococcus neoformans

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4529-4536

  Huffnagle, Gary B ^a,b   Toews, Galen B ^a   Burdick, Marie D ^a   Boyd, Michael B ^a   McAllister, Kevin S ^a   McDonald, Roderick A ^a   Kunkel, Steven L ^b   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CBA MOUSE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOLOGY; KINETICS; LUNG MYCOSIS; MICROBIOLOGY; MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; KINETICS; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED CBA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030588635     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Diamond, R. D. 1990. Cryptococcus neoformans. In Principles and Practice of Infectious Diseases, 3rd Ed. G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds. Churchill Livingstone, New York, pp. 1980-1989.
2. Murphy, J. W. 1989. Cryptococcosis. In Immunology of the Fungal Diseases. R. A. Cox, ed. CRC Press, Boca Raton, pp. 93-138.
3. Huffnagle, G. B., and M. F. Lipscomb. 1992. Animal model of human disease: pulmonary cryptococcosis. Am. J. Pathol. 141:1517.
4. Dismukes, W., G. Cloud, H. Gallis, T. Kerkering, G. Medoff, P. Craven, L. Kaplowitz, J. Fisher, C. Gregg, and C. Bowles. 1987. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med. 317:334.
5. + T cells. J. Exp. Med. 173:793.
6. Curtis, J. L., G. B. Huffnagle, G. H. Chen, M. L. Warnock, M. R. Gyetko, R. A. McDonald, P. J. Scott, and G. B. Toews. 1994. Experimental murine pulmonary cryptococcosis: differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest. 71:113.
7. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790.
8. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Stricter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated immunity and pulmonary inflammation by a high melanin-producing strain of C. neoformans. J. Immunol. 155:3507.
9. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
10. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685.
11. Lovchik, J., and M. Lipscomb. 1993. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 9:617.
12. Levitz, S., and M. Dupont. 1993. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J. Clin. Invest. 91:1490.
13. Murphy, J., M. Hidore, and S. Wong. 1993. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J. Clin. Invest. 91:1553.
14. Bulmer, G., and J. Tacker. 1975. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infect. Immun. 11:73.
15. Kozel, T., B. Highison, and C. Stratton. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect. Immun. 43:574.
16. Mody, C. H., C. L. Tyler, R. G. Sitrin, C. Jackson, and G. B. Toews. 1991. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am. J. Respir. Cell Mol. Biol. 5:19.
17. Chen, G. H., J. L. Curtis, C. H. Mody, P. J. Christensen, L. R. Armstrong, and G. B. Toews. 1994. Effect of granulocyte-macrophage stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol. 152:724.
18. + T cells. J. Exp. Med. 173:755.
19. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472.
20. + T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med. 121:765.
21. Lovchik, J. A., C. R. Lyons, and M. F. Lipscomb. 1995. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:116.
22. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487.
23. Stricter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor alpha in disease states and inflammation. Crit. Care Med. 21:S447.
24. Yokota, S., T. D. Geppert, and P. E. Lipsky. 1988. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor alpha. J. Immunol. 140:531.
25. Shalaby, M. R., T. Espevik, G. C. Rice, A. J. Ammann, I. S. Figari, G. E. Ranges, and M. A. Palladino. 1988. The involvement of human tumor necrosis factors alpha and beta in the mixed lymphocyte reaction. J. Immunol. 141:499.
26. Ranges, G. E., I. S. Figari, T. Espevik, and M. A. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166:991.
27. Joseph, A. L., and D. L. Boros. 1993. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J. Immunol. 151:5461.
28. Amiri, P., R. M. Locksley, T. G. Parslow, M. Sadick, E. Rector, D. Ritter, and J. H. McKerrow. 1992. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356:604.
29. Bromberg, J., K. Chavin, and S. Kunkel. 1992. Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J. Immunol. 148:3412.
30. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894.
31. Nakane, A., T. Minagawa, and K. Kato. 1988. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56:2563.
32. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279.
33. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor alpha and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725.
34. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complementdependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447.
35. DeMeester, S. R., M. W. Rolfe, S. L. Kunkel, D. L. Swiderski, P. M. Lincoln, G. M. Deeb, and R. M. Strieter. 1993. The bimodal expression of tumor necrosis factor alpha in association with rat lung reimplantation and allograft rejection. J. Immunol. 150:2494.
36. Smith, R. E., R. M. Stricter, S. H. Phan, N. W. Lukacs, G. B. Huffnagle, C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanoff, and S. L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J. Immunol. 153:4704.
37. Murphy, J. W., J. A. Gregory, and H. W. Larsh. 1974. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun. 9:404.
38. Murphy, J. W., and N. Pahlavan. 1979. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect. Immun. 25: 284.
39. Murphy, J. W., R. L. Mosley, R. Cherniak, G. H. Reyes, T. R. Kozel, and E. Reiss. 1988. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect. Immun. 56:424.
40. Glantz, S. A. 1992. Primer of Biostatistics, 3rd Ed. McGraw-Hill, Inc., New York.
41. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423.
42. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62:1975.
43. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, C. Tascini, T. Beccari, and T. R. Kozel. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion by human monocytes. Infect. Immun. 63:2919.
44. Leist, T. P., and R. M. Zinkernagel. 1990. Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus. Cytokine 2:29.
45. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.